Evidence map›Paper›PMID 42226808›Full record

ArticleMultiple sclerosis journal - experimental, translational and clinical

Workplace difficulties in early-stage relapsing-remitting multiple sclerosis with low physical disability.

Ángel Pérez-Sempere, Elena García-Arcelay, Jacobo Caruncho, Antonio Candeliere-Merlicco, Aida Orviz, Jesús Martín-Martínez, Raquel Piñar Morales, Elena Álvarez-Rodríguez, Eva M Pacheco, Laura Borrega and 11 more

Abstract read
In one paragraph

Article in Multiple sclerosis journal - experimental, translational and clinical. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Ángel Pérez-SempereDepartment of Neurology, Hospital Universitario General de Alicante, Universidad Miguel Hernández, Alicante, Spain.
Elena García-ArcelayMedical Department, Roche Farma, Madrid, Spain.ORCID https://orcid.org/0000-0002-2964-2045
Jacobo CarunchoAVEMPO (Asociación Viguesa de Esclerosis Múltiple de Pontevedra), Vigo, Spain.
Antonio Candeliere-MerliccoDepartment of Neurology, Hospital Rafael Méndez, Lorca, Spain.ORCID https://orcid.org/0000-0001-9978-0198
Aida OrvizDepartment of Neurology, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
Jesús Martín-MartínezDepartment of Neurology, Hospital Universitario Miguel Servet, Zaragoza, Spain.
Raquel Piñar MoralesDepartment of Neurology, Hospital Universitario Clínico San Cecilio, Granada, Spain.
Elena Álvarez-RodríguezDepartment of Neurology, Hospital Universitario Álvaro Cunqueiro, Vigo, Spain.
Eva M PachecoDepartment of Neurology, Hospital Universitario Juan Ramón Jiménez, Huelva, Spain.
Laura BorregaDepartment of Neurology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
Ignacio CasanovaDepartment of Neurology, Hospital Universitario de Torrejón, Madrid, Spain.
Ana B CamineroDepartment of Neurology, Complejo Asistencial de Ávila, Ávila, Spain.
José L Sánchez-MenoyoDepartment of Neurology, Galdakao-Usansolo University Hospital, Osakidetza (Basque Health Service), Usansolo, Spain.
Montserrat Gómez-GutiérrezDepartment of Neurology, Hospital San Pedro de Alcántara, Cáceres, Spain.
Olga CarmonaDepartment of Neurology, Fundació Salut Empordà, Figueres, Spain.
Carmen CallesDepartment of Neurology, Hospital Universitari Son Espases, Palma, Spain.
Miguel A HernándezDepartment of Neurology, Hospital Nuestra Señora de la Candelaria, Tenerife, Spain.
Pablo López-MuñozDepartment of Neurology, Hospital Llíria Arnau, Llíria, Spain.
Inés González-SuárezDepartment of Neurology, Hospital Universitario Álvaro Cunqueiro, Vigo, Spain.
Héloise JolyDepartment of Neurology, CRC SEP, Centre Hospitalier Universitaire Pasteur 2 de Nice, Université Nice Côte d´Azur, UR2CA-URRIS, Nice, France.
Jorge MaurinoMedical Department, Roche Farma, Madrid, Spain.ORCID https://orcid.org/0000-0001-9858-3555

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study evaluated perceived workplace difficulties in 128 individuals with early-stage relapsing-remitting multiple sclerosis and low physical disability. Significant workplace challenges were reported by 40.6% of participants. External barriers, including workplace inflexibility and professional-domestic life imbalance (median 23-item multiple sclerosis (MS) Work Difficulties Questionnaire-MSWDQ-23 score: 31.3, interquartile range 6.3-56.3), represented the highest burden. Women reported higher difficulty scores than men (mean MSWDQ-23 total scores: 29.9 vs. 21.2, p = 0.010). Multivariable analysis identified fatigue (OR 1.37, 95% CI 1.17-1.61) and anxiety (OR 1.21, 95% CI 1.05-1.38) as the only independent predictors of significant workplace difficulty (p < 0.001). These findings demonstrate a significant dissociation between physical disability and functional outcomes. Vocational vulnerability is driven by non-motor symptoms rather than overt neurological impairment. Proactive clinical screening for these factors is essential to mitigate work instability and preserve long-term professional trajectories.

Indexed as

anxietyemploymentfatiguegender disparityMultiple sclerosiswork difficulties

Identifiers

PMID42226808
PMCPMC13222446

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.